Announced
Synopsis
BDC Capital, a private equity firm, completed the acquisition of a minority stake in Genacol, a nutrition supplement retailer. Financial terms were not disclosed. “We are extremely proud to be able to count on the support of a quality financial partner such as BDC Capital to help us pursue our long-term growth plan both in Canada and on international markets. BDC Capital has taken note of the significant growth we have posted in recent years and has agreed to invest in our growth strategy, which is very promising for the future of the Genacol brand in the long term," Martin Vidal, Genacol President and CEO.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.